Status:
RECRUITING
Nomogram to Predict Breast Cancer Related Lymphedema
Lead Sponsor:
Wuhan University
Conditions:
Breast Cancer
Axillary Lymph Node Dissection
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
It has been hypothesized that damaged arm lymphatic drainage is associated with the arm lymphedema after axillary lymph node dissection (ALND). However, the majority of breast cancer patients with com...
Eligibility Criteria
Inclusion
- Patients aged 18 years or older with T1-3 invasive breast cancer;
- Clinically node-positive breast cancer, defined as positive on preoperative axillary palpation, ultrasound examination, and computed tomography scan with contrast;
- Patients who underwent mastectomy with a positive sentinel lymph node (SLN);
- Patients who underwent breast-conserving surgery containing more than two positive SLNs.
Exclusion
- Neoadjuvant chemotherapy;
- Previous history of breast cancer.
Key Trial Info
Start Date :
December 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04665882
Start Date
December 11 2020
End Date
December 31 2027
Last Update
December 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China, 430071